PGI2 production and angiotensin converting enzyme activity in cultured porcine pulmonary artery endothelial cells treated with paraquat. 1993

N Tamaru, and K Watanabe, and M Yoshida
2nd Department of Internal Medicine, School of Medicine, Fukuoka University, Japan.

The herbicide paraquat (PQ) is known to cause acute pulmonary edema at toxic dose and to induce morphologic changes in alveolar epithelial cells, even in the early phase of toxicity. However, whether the pulmonary vascular endothelial cells are specifically vulnerable to PQ is still controversial. To investigate the direct toxic and metabolic effects of PQ on pulmonary vascular endothelial cells, cultured porcine pulmonary artery endothelial cells (PPAEC) were evaluated. A dose of 10(-4) M of PQ inhibited the growth of endothelial cells. The thrombin- and bradykinin-stimulated production of prostacyclin (PGI2) by PPAEC was significantly enhanced, and the angiotensin converting enzyme (ACE) activity of cell lysate of PPAEC was significantly suppressed after incubation for 24 h with 10(-4) M PQ. No further enhancement of PGI2 production in response to thrombin after 48 h of incubation was demonstrated. These alterations in arachidonic acid metabolism and ACE activity did not result from the cytotoxicity of PQ, because the release of lactate dehydrogenase (LDH) into the culture medium increased only after 72 h incubation with PQ. Incubation for more than 48 h induced an obvious toxis effect on PPAEC.

UI MeSH Term Description Entries
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D007770 L-Lactate Dehydrogenase A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist. Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D010269 Paraquat A poisonous dipyridilium compound used as contact herbicide. Contact with concentrated solutions causes irritation of the skin, cracking and shedding of the nails, and delayed healing of cuts and wounds. Methyl Viologen,Gramoxone,Paragreen A,Viologen, Methyl
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D011651 Pulmonary Artery The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. Arteries, Pulmonary,Artery, Pulmonary,Pulmonary Arteries
D001920 Bradykinin A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter. Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,Bradykinin Acetate, (9-D-Arg)-Isomer,Bradykinin Diacetate,Bradykinin Hydrochloride,Bradykinin Triacetate,Bradykinin, (1-D-Arg)-Isomer,Bradykinin, (2-D-Pro)-Isomer,Bradykinin, (2-D-Pro-3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (2-D-Pro-7-D-Pro)-Isomer,Bradykinin, (3-D-Pro)-Isomer,Bradykinin, (3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (5-D-Phe)-Isomer,Bradykinin, (5-D-Phe-8-D-Phe)-Isomer,Bradykinin, (6-D-Ser)-Isomer,Bradykinin, (7-D-Pro)-Isomer,Bradykinin, (8-D-Phe)-Isomer,Bradykinin, (9-D-Arg)-Isomer,Arg Pro Pro Gly Phe Ser Pro Phe Arg
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

N Tamaru, and K Watanabe, and M Yoshida
September 1981, Journal of cellular physiology,
N Tamaru, and K Watanabe, and M Yoshida
February 1991, Journal of hypertension,
N Tamaru, and K Watanabe, and M Yoshida
October 1993, British journal of pharmacology,
N Tamaru, and K Watanabe, and M Yoshida
July 1986, The American review of respiratory disease,
N Tamaru, and K Watanabe, and M Yoshida
January 1981, Clinical and experimental pharmacology & physiology,
N Tamaru, and K Watanabe, and M Yoshida
December 1987, Biochemical and biophysical research communications,
N Tamaru, and K Watanabe, and M Yoshida
May 1979, The Journal of clinical investigation,
N Tamaru, and K Watanabe, and M Yoshida
February 1992, Journal of cellular physiology,
N Tamaru, and K Watanabe, and M Yoshida
May 1985, The Journal of clinical investigation,
Copied contents to your clipboard!